<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-93295" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Corneal Dystrophy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Moshirfar</surname>
            <given-names>Majid</given-names>
          </name>
          <aff>University of Utah/John Moran Eye Center; Hoopes Vision/HDR Research Center; Utah Lions Eye Bank</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bennett</surname>
            <given-names>Phillip</given-names>
          </name>
          <aff>Rocky Vista University College of Osteopathic Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ronquillo</surname>
            <given-names>Yasmyne</given-names>
          </name>
          <aff>Hoopes Vision Research Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Majid Moshirfar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Phillip Bennett declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Yasmyne Ronquillo declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>7</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-93295.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Corneal dystrophies are a collection of genetic diseases that affect corneal transparency and refraction due to increased deposition of abnormal material. This activity will review the classification of these diseases, their clinical presentations, diagnostic approaches, and clinical management by an interprofessional team.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the corneal dystrophies based on the affected anatomical layer.</p></list-item><list-item><p>Outline various corneal dystrophies based on genetic etiology, history, physical exam findings, and laboratory diagnostics.</p></list-item><list-item><p>Review the management of corneal dystrophies, from non-invasive treatments to corneal transplantation, as well as the risks and complications of surgical intervention.</p></list-item><list-item><p>Summarize an interprofessional team-based approach to the management of corneal dystrophies for early diagnosis, proper treatment and improved outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=93295&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=93295">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-93295.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Corneal dystrophy (CD)&#x000a0;is most recently defined as&#x000a0;a collection of&#x000a0;rare&#x000a0;hereditary&#x000a0;non-inflammatory disorders&#x000a0;of abnormal deposition of substances in the cornea.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;CD was coined in 1890&#x000a0;by&#x000a0;Arthur&#x000a0;Groenouw&#x000a0;and&#x000a0;Hugo&#x000a0;Biber, and the efforts of&#x000a0;Ernst&#x000a0;Fuchs,&#x000a0;Wilhelm&#x000a0;Uhthoff, and&#x000a0;Yoshiharu&#x000a0;Yoshida solidified the foundation of the understanding of these diseases.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;As proposed in 2015 by the International Classification of Corneal Dystrophies (IC3D), CD is sub-classified&#x000a0;by the anatomic location&#x000a0;affected: epithelial/subepithelial, epithelial-stromal, stromal, and endothelial dystrophies.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;Discoveries and unique case studies continue to broaden our understanding and classification of these&#x000a0;diseases;&#x000a0;therefore,&#x000a0;it is difficult to categorize every single dystrophy solely into these four major labels.&#x000a0;&#x000a0;</p>
        <p>The objective of this article is to present an overview of the evaluation and management for the most prominent and understood variants of CD.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;Highlights of these dystrophies will be discussed. However, further in-depth discussion on these dystrophies will be in separate StatPearls articles.&#x000a0;</p>
        <p>Patients with CD can be asymptomatic, but if symptoms occur, they typically experience&#x000a0;bilateral visual acuity loss, typically in the form of irregular astigmatism.&#x000a0;Depending on the corneal layer affected, patients&#x000a0;may also&#x000a0;manifest with&#x000a0;photophobia, dry eyes,&#x000a0;corneal edema,&#x000a0;and recurrent corneal erosions,&#x000a0;especially with epithelial-based CD, which&#x000a0;causes&#x000a0;considerable pain. Symptoms can begin at any age, depending on the diagnosis.<xref ref-type="bibr" rid="article-93295.r2">[2]</xref>&#x000a0;Treatment can range from conservative measures to corneal transplantation.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r2">[2]</xref>&#x000a0;&#x000a0;</p>
        <p>CD is a significant but rare ocular disease. The genetic component of this disease is important for patients to understand, especially for affected patients involved with family planning. As we begin to understand genetics in greater detail, better evaluation and treatments for CD will come to fruition.&#x000a0;</p>
        <p>The objective of this article is to&#x000a0;present an overview of the&#x000a0;general evaluation and management for the most prominent and understood variants&#x000a0;of CD.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;Highlights of these dystrophies will be covered, but the author intends to elaborate on these dystrophies separately in other StatPearls articles.&#x000a0;The variants of CD based on their new anatomic classifications&#x000a0;in&#x000a0;IC3D&#x000a0;are<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>:&#x000a0;</p>
        <p><bold>Epithelial and subepithelial dystrophies</bold>&#x000a0;&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Epithelial basement membrane&#x000a0;corneal dystrophy&#x000a0;(EBMCD),&#x000a0;also&#x000a0;previously&#x000a0;known as map-finger-dot dystrophy,&#x000a0;Cogan microcystic dystrophy,&#x000a0;and&#x000a0;anterior basement&#x000a0;membrane&#x000a0;dystrophy.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r2">[2]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Epithelial recurrent erosion dystrophies (EREDs)&#x000a0;which&#x000a0;includes Franceschetti corneal dystrophy, dystrophia&#x000a0;smolandiensis, and dystrophia&#x000a0;helsinglandica<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Subepithelial mucinous corneal dystrophy (SMCD)&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Meesmann&#x000a0;corneal dystrophy&#x000a0;(MECD)&#x000a0;also known as&#x000a0;juvenile epithelial corneal dystrophy<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r3">[3]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Lisch&#x000a0;epithelial corneal dystrophy&#x000a0;(LECD)&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Gelatinous drop-like corneal dystrophy&#x000a0;(GDLD)&#x000a0;</p>
          </list-item>
        </list>
        <p><bold>Epithelial-Stromal Dystrophies</bold>&#x000a0;(still included under epithelial and subepithelial dystrophies)<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Lattice corneal dystrophy&#x000a0;(LCD),&#x000a0;with its subtypes: type I (TGFBI mutation)&#x000a0;and&#x000a0;type II (familial amyloidosis Finnish type),<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;including LCD variants&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Granular&#x000a0;corneal dystrophy&#x000a0;(GCD), types I and II (Avellino-type)<xref ref-type="bibr" rid="article-93295.r2">[2]</xref>&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Reis-B&#x000fc;ckler&#x02019;s&#x000a0;corneal dystrophy&#x000a0;(RBCD)&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Thiel-Behnke corneal dystrophy (honeycomb dystrophy)<xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;(TBCD)&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Stromal dystrophies</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Macular&#x000a0;corneal dystrophy&#x000a0;(MCD)&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Schnyder corneal dystrophy (SCD)&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Congenital stromal corneal dystrophy (CSCD)&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Fleck corneal dystrophy (FCD)&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Posterior amorphous corneal dystrophy (PACD)&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Pre-Descemet corneal dystrophy (PDCD)&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Central cloudy dystrophy of francois (CCDF)&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Endothelial Corneal Dystrophies</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Fuchs endothelial corneal dystrophy (FECD)&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Posterior polymorphous corneal dystrophy (PPCD)&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Congenital hereditary endothelial dystrophy (CHED)&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>X-linked endothelial corneal dystrophy (XECD)&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-93295.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Clinicians need&#x000a0;to distinguish corneal degeneration from corneal dystrophies.&#x000a0;Corneal degeneration is a broad term for afflictions that cause&#x000a0;alterations to the corneal structure&#x000a0;due to a multitude of factors, such as trauma, infection,&#x000a0;increasing age,&#x000a0;and other environmental factors.&#x000a0;Corneal&#x000a0;dystrophy is a&#x000a0;disorder distinguished from general corneal degeneration by a genetic etiology, either inherited or through de novo mutation.<xref ref-type="bibr" rid="article-93295.r2">[2]</xref>&#x000a0;Historically, when an understanding of genetics was limited, CD was differentiated by its bilateral, symmetric, insidious presentation that seemed&#x000a0;not to&#x000a0;be&#x000a0;related to&#x000a0;environmental factors.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r5">[5]</xref>&#x000a0;Additionally, corneal dystrophies tend to affect vision more than corneal degeneration.&#x000a0;</p>
        <p>The IC3D categorized CD into&#x000a0;four&#x000a0;different categories, based on our genetic understanding of each disease variant: category 1 identifies a CD with the mutated gene(s) identified, category 2 identifies the locus of the mutation, category 3 is a CD without a gene or locus identified, and category 4 is reserved for new or suspicious CD.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r6">[6]</xref>&#x000a0;Many dystrophies are well understood genetically and are,&#x000a0;therefore,&#x000a0;in category 1.&#x000a0;Lisch&#x000a0;epithelial CD and XECD are in category 2.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;Others,&#x000a0;such as ERED and posterior&#x000a0;amorphous&#x000a0;CD&#x000a0;(category 3) and&#x000a0;subepithelial&#x000a0;mucinous&#x000a0;CD&#x000a0;(category 4),&#x000a0;are not yet well understood&#x000a0;genetically.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;&#x000a0;</p>
        <p>Many corneal dystrophies are inherited in an autosomal dominant pattern.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r4">[4]</xref><xref ref-type="bibr" rid="article-93295.r7">[7]</xref>&#x000a0;There are&#x000a0;autosomal recessive CDs as well, and&#x000a0;studies suggest that&#x000a0;CD&#x000a0;can be&#x000a0;a result of consanguineous families.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;Lisch&#x000a0;epithelial CD and XECD are X-linked dominant diseases.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;These X-linked disorders may be associated with other diseases that are concomitantly inherited, such as keratosis pilaris, or congenital, inflammatory papules that result in hair loss.<xref ref-type="bibr" rid="article-93295.r8">[8]</xref><xref ref-type="bibr" rid="article-93295.r9">[9]</xref>&#x000a0;&#x000a0;&#x000a0;</p>
        <p>While many genes could be affected and lead to&#x000a0;corneal&#x000a0;dystrophy, some genes have been&#x000a0;&#x000a0;confirmed:&#x000a0;</p>
        <p>
<bold>Transforming Growth Factor, Beta Induced (TGFBI)</bold>
</p>
        <p>This gene is altered in epithelial-based dystrophies such as type I LCD, GCD types I and II, EBMCD,&#x000a0;Reis-B&#x000fc;cklers&#x000a0;CD, and Thiel-Behnke CD.<xref ref-type="bibr" rid="article-93295.r2">[2]</xref><xref ref-type="bibr" rid="article-93295.r4">[4]</xref><xref ref-type="bibr" rid="article-93295.r10">[10]</xref><xref ref-type="bibr" rid="article-93295.r11">[11]</xref>&#x000a0;Also known as BIGH3&#x000a0;or&#x000a0;keratoepithelin, this gene&#x000a0;is found on chromosome 5, and&#x000a0;the function of the protein it produces&#x000a0;is to&#x000a0;link to collagens and&#x000a0;provide support in the&#x000a0;corneal&#x000a0;extracellular matrix.<xref ref-type="bibr" rid="article-93295.r12">[12]</xref>&#x000a0;Some variants of LCD are&#x000a0;autosomal recessive, all presenting&#x000a0;with similar symptoms&#x000a0;as the other types of LCD, but with different mutations on the&#x000a0;keratoepithelin&#x000a0;gene.<xref ref-type="bibr" rid="article-93295.r13">[13]</xref><xref ref-type="bibr" rid="article-93295.r14">[14]</xref>&#x000a0;</p>
        <p><bold>Gelsolin</bold>:&#x000a0;Type II LCD (Finnish type)&#x000a0;is caused by a mutated form&#x000a0;of&#x000a0;gelsolin. This protein normally functions in removing excess actin filaments from plasma, but&#x000a0;that&#x000a0;can cause systemic amyloidosis&#x000a0;when mutated.<xref ref-type="bibr" rid="article-93295.r15">[15]</xref><xref ref-type="bibr" rid="article-93295.r16">[16]</xref>&#x000a0;This leads to amyloid deposition in vascular, skin, and nerve tissue, as well as the cornea.<xref ref-type="bibr" rid="article-93295.r17">[17]</xref>&#x000a0;&#x000a0;</p>
        <p><bold>KRT</bold>:&#x000a0;Meesmann&#x000a0;CD is&#x000a0;an autosomal dominant disease&#x000a0;caused by a mutation&#x000a0;in&#x000a0;the Keratin gene,&#x000a0;specifically KRT3 and KRT12,&#x000a0;which&#x000a0;normally produce intermediate filaments inside cells to provide structure to keratocytes.<xref ref-type="bibr" rid="article-93295.r18">[18]</xref>&#x000a0;The dysfunction of keratin&#x000a0;3 and 12&#x000a0;weakens epithelial cells to the point&#x000a0;of&#x000a0;discohesion.<xref ref-type="bibr" rid="article-93295.r3">[3]</xref><xref ref-type="bibr" rid="article-93295.r4">[4]</xref><xref ref-type="bibr" rid="article-93295.r18">[18]</xref><xref ref-type="bibr" rid="article-93295.r19">[19]</xref>&#x000a0;</p>
        <p><bold>UBIAD1:</bold>&#x000a0;Schnyder CD is caused by a mutation in the&#x000a0;UbiA&#x000a0;prenyltransferase&#x000a0;domain-containing protein 1&#x000a0;gene, which is involved in vitamin K and coenzyme Q metabolism.<xref ref-type="bibr" rid="article-93295.r20">[20]</xref>&#x000a0;&#x000a0;</p>
        <p><bold>TACSTD-2:</bold>&#x000a0;An autosomal recessive&#x000a0;mutation of&#x000a0;tumor-associated calcium signal transducer-2 is found in&#x000a0;gelatinous&#x000a0;drop-like&#x000a0;dystrophy.<xref ref-type="bibr" rid="article-93295.r2">[2]</xref><xref ref-type="bibr" rid="article-93295.r21">[21]</xref>&#x000a0;</p>
        <p><bold>CHST6</bold>:&#x000a0;Carbohydrate sulfotransferase 6 is&#x000a0;found in&#x000a0;MCD and inherited in an autosomal recessive fashion.<xref ref-type="bibr" rid="article-93295.r22">[22]</xref>&#x000a0;The gene encodes&#x000a0;for a sulfate-transferring protein.<xref ref-type="bibr" rid="article-93295.r2">[2]</xref>&#x000a0;</p>
        <p><bold>SLC4A11:</bold>&#x000a0;Found in&#x000a0;FECD, late-onset, as well as&#x000a0;congenital hereditary endothelial dystrophy, this gene produces a bicarbonate transporter protein.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref><xref ref-type="bibr" rid="article-93295.r23">[23]</xref><xref ref-type="bibr" rid="article-93295.r24">[24]</xref>&#x000a0;</p>
        <p><bold>ZEB1</bold>:&#x000a0;Zinc finger E-box-binding homeobox 1, formerly known as TCF8,&#x000a0;leads to Posterior Polymorphous CD,&#x000a0;as well as FECD,&#x000a0;and is responsible for embryonic development and type I collagen expression.<xref ref-type="bibr" rid="article-93295.r24">[24]</xref><xref ref-type="bibr" rid="article-93295.r25">[25]</xref><xref ref-type="bibr" rid="article-93295.r26">[26]</xref>&#x000a0;</p>
        <p><bold>Phosphoinositide kinase FYVE mutations (formerly PIP5K3):</bold>&#x000a0;This mutated gene, which produces&#x000a0;proteins that help regulate endosomal function, is found in Fleck CD.<xref ref-type="bibr" rid="article-93295.r27">[27]</xref>&#x000a0;</p>
        <p><bold>COL8A2</bold>:&#x000a0;Early-onset&#x000a0;FECD, if inherited, is an autosomal dominant disease&#x000a0;caused by a mutation in COL8A2.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r28">[28]</xref>&#x000a0;The aberrant protein involved is alpha 2 collagen VIII.<xref ref-type="bibr" rid="article-93295.r6">[6]</xref>&#x000a0;Mutations in the FCD1, FCD2, FCD3, and FCD4 genes&#x000a0;that can occur&#x000a0;in late-onset&#x000a0;FECD.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r7">[7]</xref><xref ref-type="bibr" rid="article-93295.r24">[24]</xref><xref ref-type="bibr" rid="article-93295.r28">[28]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-93295.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Fuchs endothelial corneal dystrophy is the most common among the corneal dystrophies.<xref ref-type="bibr" rid="article-93295.r6">[6]</xref>&#x000a0;Globally in 2012, 39% of corneal transplants were to correct FECD.<xref ref-type="bibr" rid="article-93295.r24">[24]</xref>&#x000a0;Even so, corneal dystrophies are rare diseases.&#x000a0;In the United States, less than 0.01% of Americans are affected by CD.<xref ref-type="bibr" rid="article-93295.r29">[29]</xref>&#x000a0;Another&#x000a0;study&#x000a0;showed that around 530 persons out of a million in the United States have an endothelial-type CD,&#x000a0;and&#x000a0;5-10 persons per million have&#x000a0;a granular, macular or lattice-type CD.<xref ref-type="bibr" rid="article-93295.r29">[29]</xref>&#x000a0;Only four families have been reported to have CSCD.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;&#x000a0;&#x000a0;</p>
        <p>Demographically, CD&#x000a0;has a&#x000a0;variety of presentations. Both genders are equally affected by CD, although it has been shown that Fuchs CD is more common in females.<xref ref-type="bibr" rid="article-93295.r28">[28]</xref><xref ref-type="bibr" rid="article-93295.r30">[30]</xref>&#x000a0;FECD&#x000a0;is more prevalent&#x000a0;in patients of Caucasian descent.<xref ref-type="bibr" rid="article-93295.r24">[24]</xref>&#x000a0;CD can be more prevalent based on global regions, such as GCD type II being predominantly European, GDLD common in Japan,&#x000a0;Meesmann&#x000a0;CD is found in families with German and Danish descent,&#x000a0;and LCD type II being found in patients of Finnish descent.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref><xref ref-type="bibr" rid="article-93295.r31">[31]</xref><xref ref-type="bibr" rid="article-93295.r32">[32]</xref>&#x000a0;Some dystrophies present as early as birth, such as Fleck&#x000a0;CD, CHED,&#x000a0;and CSCD,&#x000a0;while others develop later on in life, typically in the&#x000a0;second&#x000a0;or&#x000a0;third&#x000a0;decade of life, such as late-onset FECD and LCD type II.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r7">[7]</xref><xref ref-type="bibr" rid="article-93295.r4">[4]</xref><xref ref-type="bibr" rid="article-93295.r24">[24]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-93295.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The cornea&#x000a0;consists of&#x000a0;several&#x000a0;layers. From superficial to deep, the layers are&#x000a0;squamous epithelium, anterior basement layer (Bowman&#x02019;s), a stroma comprised of keratocytes and collagen, a posterior basement membrane (Descemet&#x02019;s), and an endothelial layer. The major function of the cornea is to provide a medium in which light may be refracted and focused on the retina for visual acuity.<xref ref-type="bibr" rid="article-93295.r33">[33]</xref>&#x000a0;The cornea is&#x000a0;a transparent barrier between the inner constituents of the eye&#x000a0;and&#x000a0;the outside world and&#x000a0;is bathed in&#x000a0;the tear film, which creates a smooth surface for the refraction of light as well as immunologic protection.<xref ref-type="bibr" rid="article-93295.r33">[33]</xref>&#x000a0;</p>
        <p>Defining&#x000a0;corneal&#x000a0;dystrophies&#x000a0;depends on which layers of the cornea are affected. Alterations in proteins cause deposits within the cells of the cornea, leading to&#x000a0;abnormal&#x000a0;vision examination findings.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;In fact, because of our historical limitation in understanding genetics, CD was formerly diagnosed based on the patterns of deposits found.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;These patterns include granular, lattice, gelatinous,&#x000a0;and macular dystrophies, among others.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;As the stroma is the thickest portion of the cornea, and hence, the most responsible for transparency and light refraction, the accumulations of deposits often found in CD&#x000a0;interfere with refraction, thus leading to loss of visual acuity.<xref ref-type="bibr" rid="article-93295.r33">[33]</xref>&#x000a0;</p>
        <p>The squamous epithelium is highly innervated by unmyelinated nerves, which function to increase tear production and to signal the blink reflex.<xref ref-type="bibr" rid="article-93295.r33">[33]</xref>&#x000a0;It is nourished and oxygenated through tears since no blood vessels penetrate through to the outermost layer.<xref ref-type="bibr" rid="article-93295.r33">[33]</xref>&#x000a0;Patients with epithelial-type CD&#x000a0;will&#x000a0;be&#x000a0;predisposed to corneal erosions, in which&#x000a0;the patient&#x000a0;suffers ocular pain due&#x000a0;to the&#x000a0;disruption&#x000a0;and sloughing&#x000a0;of&#x000a0;the epithelium, especially&#x000a0;during nighttime&#x000a0;hypoxia.<xref ref-type="bibr" rid="article-93295.r5">[5]</xref>&#x000a0;Another common complication in CD is corneal haze, which is caused by inflammatory&#x000a0;mediators and subepithelial fibrosis&#x000a0;of Bowman&#x02019;s membrane and the overlying&#x000a0;stroma. This fibrotic change leads to loss of visual acuity.<xref ref-type="bibr" rid="article-93295.r5">[5]</xref>&#x000a0;</p>
        <p>The&#x000a0;primary&#x000a0;function of Descemet&#x02019;s membrane and the endothelial cells&#x000a0;is to&#x000a0;pump ions&#x000a0;against a gradient&#x000a0;to maintain corneal dehydration or&#x000a0;deturgescence.<xref ref-type="bibr" rid="article-93295.r34">[34]</xref>&#x000a0;Gap junctions in between endothelial cells, as well as hemidesmosomes attaching to&#x000a0;the posterior basement membrane,&#x000a0;serve as a barrier against&#x000a0;aqueous&#x000a0;humor entering the drier environment of the cornea.<xref ref-type="bibr" rid="article-93295.r33">[33]</xref>&#x000a0;In FECD,&#x000a0;a decrease in the number of Na/K ATPase pumps&#x000a0;in the endothelium&#x000a0;leads&#x000a0;to stromal edema.<xref ref-type="bibr" rid="article-93295.r6">[6]</xref><xref ref-type="bibr" rid="article-93295.r24">[24]</xref><xref ref-type="bibr" rid="article-93295.r35">[35]</xref>&#x000a0;In addition, the proteins involved with the genetic mutations undergo a process called the unfolded protein response, which sends cells with these proteins into apoptosis, which occurs in the endothelial cells of FECD patients.<xref ref-type="bibr" rid="article-93295.r28">[28]</xref>&#x000a0;&#x000a0;</p>
        <p>Amyloidosis is a disease of abnormal protein deposition in tissues.<xref ref-type="bibr" rid="article-93295.r36">[36]</xref>&#x000a0;Amyloid-type protein deposition can be a systemic disease or a local manifestation, depending on the aberrant protein.<xref ref-type="bibr" rid="article-93295.r36">[36]</xref>&#x000a0;It is important to note that some variants of CD fall under the category of amyloidosis, ranging from systemic diseases, such as LCD type II, to&#x000a0;localized&#x000a0;corneal deposits, such as found in GCD,&#x000a0;that stain appropriately for amyloid protein.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r36">[36]</xref></p>
      </sec>
      <sec id="article-93295.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with CD may be asymptomatic or report blurriness of vision.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;Symptomatic patients complain of eye pain, with or without light sensitivity and foreign body sensation.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r37">[37]</xref>&#x000a0;These are due to corneal erosions, or the separation of the squamous epithelial layer from the anterior basement membrane.<xref ref-type="bibr" rid="article-93295.r5">[5]</xref>&#x000a0;Pain typically occurs in the morning, after nocturnal drying of the cornea causes the epithelium to slough and be sheared off upon eyelid opening<xref ref-type="bibr" rid="article-93295.r5">[5]</xref>&#x000a0;Corneal erosions are common in&#x000a0;almost all of the epithelial-based dystrophies;&#x000a0;therefore, all the variants should be&#x000a0;considered in&#x000a0;the differential diagnosis.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r4">[4]</xref><xref ref-type="bibr" rid="article-93295.r5">[5]</xref>&#x000a0;Generally,&#x000a0;CD presents&#x000a0;with visual alterations&#x000a0;bilaterally.&#x000a0;However,&#x000a0;some dystrophies such as&#x000a0;Posterior Polymorphous CD&#x000a0;may present unilaterally.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;Congenital stromal CD presents with strabismus at birth.<xref ref-type="bibr" rid="article-93295.r38">[38]</xref>&#x000a0;&#x000a0;</p>
        <p>Slit-lamp (biomicroscopy) examination&#x000a0;findings&#x000a0;are usually&#x000a0;the first&#x000a0;step in differentiating the different types of corneal&#x000a0;dystrophies.&#x000a0;Symptoms often group among the dystrophies based on anatomic location.&#x000a0;An overview of typical&#x000a0;symptoms and&#x000a0;biomicroscopic findings are presented below, organized by anatomical classification.&#x000a0;A more detailed description of these findings will be mentioned in other StatPearls articles on each separate dystrophy.&#x000a0;The symptoms and findings are:&#x000a0;</p>
        <p><bold>Epithelial and subepithelial dystrophies</bold>:&#x000a0;Patients will usually suffer from recurrent corneal erosions&#x000a0;with these dystrophies, with different degrees of severity.&#x000a0;History and&#x000a0;biomicroscopy&#x000a0;findings are as follows:&#x000a0;</p>
        <p><bold>EB</bold><bold>M</bold><bold>CD</bold>:&#x000a0;This CD&#x000a0;presents&#x000a0;with irregular,&#x000a0;gray,&#x000a0;map-like patches or intraepithelial (Cogan) microcysts.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;Subepithelial pebble-like inclusions (Blebs) have been identified&#x000a0;(see figure 1).<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;Symptoms include mild to severe corneal erosions, worse in the morning, as well as blurriness, photophobia,&#x000a0;and diplopia.<xref ref-type="bibr" rid="article-93295.r5">[5]</xref>&#x000a0;</p>
        <p><bold>Meesmann CD</bold>:&#x000a0;While MECD typically presents asymptomatically, or with mild symptoms&#x000a0;of visual acuity loss and eye irritation, it can progress to painful erosions due to foreign body sensation, and potentially be severe enough to cause significant subepithelial fibrosis and vision loss.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r19">[19]</xref>&#x000a0;Other common symptoms include photophobia&#x000a0;and&#x000a0;increased lacrimation.<xref ref-type="bibr" rid="article-93295.r32">[32]</xref>&#x000a0;Biomicroscopy&#x000a0;presents with&#x000a0;microcysts described as tiny bubbles&#x000a0;at the level of the epithelium&#x000a0;(see figure 1), usually in the interpalpebral area, but it has been described both centrally and peripherally.<xref ref-type="bibr" rid="article-93295.r2">[2]</xref><xref ref-type="bibr" rid="article-93295.r4">[4]</xref></p>
        <p><bold>ERED</bold><bold>:&#x000a0;</bold>The recurrent erosions start in the first decade,&#x000a0;and episodes can be severe and last for up to a week.<xref ref-type="bibr" rid="article-93295.r5">[5]</xref>&#x000a0;These erosions often occur at nighttime.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;On slit-lamp exam,&#x000a0;and&#x000a0;patients&#x000a0;may present with diffuse bilateral subepithelial opacifications, potentially progressing to keloid-appearing nodules,&#x000a0;later in life.<xref ref-type="bibr" rid="article-93295.r39">[39]</xref><xref ref-type="bibr" rid="article-93295.r40">[40]</xref>&#x000a0;</p>
        <p><bold>Subepithelial Mucinous CD</bold><bold>:&#x000a0;</bold>Similar to ERED, SMCD&#x000a0;may&#x000a0;present with subepithelial&#x000a0;opacifications, with most of the findings in the center of the cornea.<xref ref-type="bibr" rid="article-93295.r39">[39]</xref><xref ref-type="bibr" rid="article-93295.r40">[40]</xref>&#x000a0;As opposed to ERED, painful erosions tend to subside in adolescence.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;</p>
        <p><bold>Lisch&#x000a0;Epithelial CD</bold><bold>:</bold>&#x000a0;presents with gray whorled to band&#x000a0;or&#x000a0;club-shaped densities, even&#x000a0;feather-shaped&#x000a0;(see figure 2).<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r41">[41]</xref>&#x000a0;Patients may present with&#x000a0;painless&#x000a0;mild visual acuity loss, but many are asymptomatic&#x000a0;until the sixth decade.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref><xref ref-type="bibr" rid="article-93295.r41">[41]</xref>&#x000a0;</p>
        <p><bold>Gelatinous&#x000a0;Drop-Like&#x000a0;Dystrophy</bold><bold>:</bold>&#x000a0;GDLD starts with a presentation similar to band keratopathy, but it progresses to&#x000a0;mulberry-like subepithelial nodules&#x000a0;that grow in size over&#x000a0;time&#x000a0;(see figure 2).<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r31">[31]</xref>&#x000a0;These nodules significantly alter vision. Symptoms and signs include photophobia, increased superficial vascularization with redness, and increased tear production.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref></p>
        <p><bold>Epithelial-Stromal Dystrophies</bold>:&#x000a0;Not only will patients have corneal erosions, but visual acuity loss&#x000a0;and photophobia&#x000a0;may occur as well, due to stromal involvement.&#x000a0;&#x000a0;</p>
        <p><bold>Lattice CD</bold>:&#x000a0;On&#x000a0;biomicroscopy,&#x000a0;LCD presents with linear/branching opacities, forming a&#x000a0;ropy&#x000a0;lattice structure&#x000a0;(see figure 3).<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;the amyloidotic ocular symptoms from LCD type II are commonly found in conjunction with&#x000a0;Meretoja&#x000a0;syndrome, which involves glaucoma, systemic findings such as cutis&#x000a0;laxa&#x000a0;(loose skin),&#x000a0; and a signature lax, mask-like face due to facial nerve paralysis.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r17">[17]</xref><xref ref-type="bibr" rid="article-93295.r42">[42]</xref>&#x000a0;Some LCD variants&#x000a0;appear in the 4th&#x000a0;decade of life, presenting with similar signs and symptoms.<xref ref-type="bibr" rid="article-93295.r13">[13]</xref>&#x000a0;</p>
        <p><bold>Granular&#x000a0;CD</bold>:&#x000a0;If patients are symptomatic, corneal erosions starting in the first decade are likely to be seen. Visual imparity usually presents in the 5th&#x000a0;decade of life. Biomicroscopy&#x000a0;will present&#x000a0;with crumb&#x000a0;or&#x000a0;flake-like opacities, with the spaces between the opacities clear of deposits&#x000a0;(see figure 3).<xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;Type II presents with granular and lattice-like findings on the cornea.<xref ref-type="bibr" rid="article-93295.r2">[2]</xref>&#x000a0;</p>
        <p><bold>Reis-B&#x000fc;cklers&#x000a0;CD:</bold>&#x000a0;This dystrophy can&#x000a0;present&#x000a0;in childhood&#x000a0;with geographic, map-like findings similar to EMBCD&#x000a0;(see figure 4).<xref ref-type="bibr" rid="article-93295.r43">[43]</xref>&#x000a0;The patient will also suffer from painful erosions.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;These will tend to fade away by the second or third decade of life, but visual imparity is often seen at this time and is associated with photophobia and corneal haze.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r2">[2]</xref><xref ref-type="bibr" rid="article-93295.r4">[4]</xref><xref ref-type="bibr" rid="article-93295.r44">[44]</xref></p>
        <p><bold>Thiel-Behnke CD</bold><bold>:</bold> The patient will present with symptoms&#x000a0;like&#x000a0;RBCD;&#x000a0;however, they tend to be milder in TBCB, with visual impairment beginning later in life, and erosions&#x000a0;starting in the first or second decade.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;This dystrophy&#x000a0;presents with honeycomb-like opacities, and&#x000a0;the corneal surface will appear irregularly raised.<xref ref-type="bibr" rid="article-93295.r44">[44]</xref>&#x000a0;&#x000a0;</p>
        <p><bold>Stromal Dystrophies</bold>:&#x000a0;Corneal haze is often noted in these dystrophies, which affects visual acuity in most patients.&#x000a0;</p>
        <p><bold>M</bold><bold>acular&#x000a0;</bold><bold>CD</bold>:&#x000a0;MCD&#x000a0;presents with corneal haze and grainy,&#x000a0;ground glass-like&#x000a0;opacities,&#x000a0;made of glycosaminoglycans. (see figure 4).<xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;Its presentation on biomicroscopy has often been closely compared to GCD, and the hazy appearance in between opacities is indicative of MCD.<xref ref-type="bibr" rid="article-93295.r2">[2]</xref>&#x000a0;Typical symptoms include severe visual acuity loss and photophobia in the second to the third decade, along with mild erosions.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;Corneal thinning is present, which additionally leads to vision impairment.<xref ref-type="bibr" rid="article-93295.r2">[2]</xref><xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;This dystrophy&#x000a0;has been associated, rarely, with keratosis follicularis spinulosa decalvans, which causes hair loss of the scalp, eyebrows,&#x000a0;and eyelashes, and a mutation in the CDH3 gene.<xref ref-type="bibr" rid="article-93295.r8">[8]</xref>&#x000a0;</p>
        <p><bold>Schnyder CD</bold>:&#x000a0;Early findings&#x000a0;by the second decade&#x000a0;involve&#x000a0;central&#x000a0;crystalline subepithelial deposits&#x000a0;with&#x000a0;a stromal haze&#x000a0;that progresses to a ring-like structure.<xref ref-type="bibr" rid="article-93295.r20">[20]</xref>&#x000a0;Arcus&#x000a0;lipoides&#x000a0;is often seen&#x000a0;by the third decade.<xref ref-type="bibr" rid="article-93295.r20">[20]</xref>&#x000a0;Schnyder CD can present with hypercholesterolemia&#x000a0;and other systemic lipidic symptoms like xanthelasma.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref><xref ref-type="bibr" rid="article-93295.r20">[20]</xref>&#x000a0;Genu&#x000a0;valgum&#x000a0;has been noted in some cases.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;In addition to blurriness, advanced SCD can present with glare and decreased corneal sensitivity.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;</p>
        <p><bold>Congenital Stromal CD</bold>: CSCD typically presents with symmetric corneal clouding with white flaky stromal opacities.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;The presentation is severe enough to cause significant vision loss.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;Some patients present with strabismus and/or open-angle glaucoma.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref><xref ref-type="bibr" rid="article-93295.r2">[2]</xref>&#x000a0;</p>
        <p><bold>C</bold><bold>entral&#x000a0;</bold><bold>C</bold><bold>loudy&#x000a0;</bold><bold>D</bold><bold>ystrophy of Fran&#x000e7;ois</bold>: CCDF&#x000a0;presents with a&#x000a0;lizard-like&#x000a0;patterned gray stromal opacities, called crocodile shagreen.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r2">[2]</xref>&#x000a0;There are also areas of indistinct polygonal gray zones of stroma, surrounded by normal-appearing tissue.<xref ref-type="bibr" rid="article-93295.r45">[45]</xref>&#x000a0;Most patients are asymptomatic.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;</p>
        <p><bold>Fleck CD</bold><bold>:</bold>&#x000a0;This dystrophy&#x000a0;presents with&#x000a0;small&#x000a0;white&#x000a0;oval&#x000a0;dandruff-like opacities.<xref ref-type="bibr" rid="article-93295.r27">[27]</xref>&#x000a0;Most patients are asymptomatic.<xref ref-type="bibr" rid="article-93295.r2">[2]</xref>&#x000a0;</p>
        <p><bold>Posterior Amorphous CD</bold>: PACD&#x000a0;presents with sheet-like opacities, both centrally and peripherally,&#x000a0;along the posterior stroma.<xref ref-type="bibr" rid="article-93295.r46">[46]</xref>&#x000a0;Onset is in very young patients, such that this disease may be considered congenital.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;While iridocorneal adhesions and corneal thinning are noted, symptoms of glaucoma are not typical.&#x000a0;Visual acuity is mildly affected.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;</p>
        <p><bold>Pre-Descemet CD</bold><bold>:</bold>&#x000a0;This dystrophy&#x000a0;presents with a condition&#x000a0;similar to&#x000a0;cornea&#x000a0;farinata, which describes the accumulations as gray-white dust-like opacities&#x000a0;made of lipids on&#x000a0;biomicroscopy.<xref ref-type="bibr" rid="article-93295.r2">[2]</xref>&#x000a0;These lesions usually present later in life, and most patients are asymptomatic.<xref ref-type="bibr" rid="article-93295.r2">[2]</xref>&#x000a0;Pre-Descemet CD has often been found in conjunction with other disorders, such as ichthyosis.<xref ref-type="bibr" rid="article-93295.r47">[47]</xref>&#x000a0;</p>
        <p><bold>Endothelial dystrophies</bold>:&#x000a0;Patients with these dystrophies have blurriness and visual disturbances such as haloes around light, due to corneal edema&#x000a0;and thickness.&#x000a0;&#x000a0;</p>
        <p><bold>F</bold><bold>uchs&#x000a0;</bold><bold>E</bold><bold>ndothelial&#x000a0;</bold><bold>CD</bold>: FECD&#x000a0;presents with guttae, or drop-like conglomerates, along Descemet&#x02019;s membrane&#x000a0;(see figure 5).<xref ref-type="bibr" rid="article-93295.r7">[7]</xref>&#x000a0;These excrescences form in areas of decellularization along the endothelial layer.<xref ref-type="bibr" rid="article-93295.r6">[6]</xref>&#x000a0;Signs and symptoms include&#x000a0;corneal edema, which presents as diffuse corneal haziness that affects visual acuity.<xref ref-type="bibr" rid="article-93295.r7">[7]</xref>&#x000a0;Typically, blurriness is worse in the morning due to an increase in edema at nighttime.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;Pain and photophobia are possible due to epithelial erosions caused by fibrosis and edema.<xref ref-type="bibr" rid="article-93295.r6">[6]</xref>&#x000a0;FECD is also evaluated using the&#x000a0;Krachmer&#x000a0;scale, which counts the number of guttae found on slit-lamp examination.<xref ref-type="bibr" rid="article-93295.r6">[6]</xref>&#x000a0;Guttae tend to start in the center of the cornea.<xref ref-type="bibr" rid="article-93295.r48">[48]</xref>&#x000a0;A&#x000a0;Krachmer&#x000a0;score of 0 means no guttae present, 1 designates 0 to 12 central guttae, 2 is greater than 12 nonconfluent guttae, 3 is 1 to 2 mm of confluent guttae, 4 is 2 to 5 mm confluent guttae, while a score of 5 signifies greater than 5 mm of confluent guttae.<xref ref-type="bibr" rid="article-93295.r6">[6]</xref>&#x000a0;</p>
        <p><bold>C</bold><bold>ongenital Hereditary CD</bold>:&#x000a0;CHED presents with&#x000a0;diffuse ground glass-like corneal haze and edema, along with focal gray spotting.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r2">[2]</xref>&#x000a0;These cause blurry vision.<xref ref-type="bibr" rid="article-93295.r2">[2]</xref>&#x000a0;The autosomal recessive variant of CHED is sometimes associated with deafness.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;A significant increase in corneal thickness is noted in this disease.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;Nystagmus&#x000a0;is&#x000a0;present.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;&#x000a0;</p>
        <p><bold>Posterior Polymorphous&#x000a0;</bold><bold>CD</bold>:&#x000a0;PPCD&#x000a0;can present with a variety of&#x000a0;asymmetric&#x000a0;or unilateral&#x000a0;biomicroscopic findings, including vesicles,&#x000a0;breaking&#x000a0;bands, or&#x000a0;gray haze&#x000a0;(see figure 5).<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r49">[49]</xref>&#x000a0;The visual disturbances and pain associated with glaucoma can also present in PPCD, as it tends to form peripheral anterior synechiae (iris-angle adhesion).<xref ref-type="bibr" rid="article-93295.r2">[2]</xref><xref ref-type="bibr" rid="article-93295.r25">[25]</xref>&#x000a0;Keratoconus is often seen in patients, leading to visual acuity loss, along with corneal edema and photophobia.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r2">[2]</xref>&#x000a0;On light microscopy, it is noted that the endothelial layer changes to stratified squamous epithelium.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;</p>
        <p><bold>X-linked&#x000a0;Endothelial&#x000a0;CD</bold><bold>:</bold> XECD&#x000a0;presents with&#x000a0;diffuse milky opacities with band keratopathy as well as moon crater-like endothelial cells.<xref ref-type="bibr" rid="article-93295.r50">[50]</xref>&#x000a0;It is of note that&#x000a0;moon crater change&#x000a0;in&#x000a0;endothelial cells is&#x000a0;only&#x000a0;seen in female carriers.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;In addition, affected&#x000a0;males&#x000a0;have blurred vision and nystagmus, while females are asymptomatic.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r4">[4]</xref></p>
      </sec>
      <sec id="article-93295.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Diagnosis begins with a full eye examination,&#x000a0;with emphasis on&#x000a0;biomicroscopy, which was the original technique to observe the physical findings on the cornea.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;Light microscopy of histologic specimens&#x000a0;can help identify subtypes&#x000a0;of&#x000a0;CD.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;EBMCD&#x000a0;and&#x000a0;Meesmann&#x000a0;CD&#x000a0;display a thickened Bowman&#x02019;s&#x000a0;Layer.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r2">[2]</xref>&#x000a0;GCD type 1 presents with granular, snowflake-like hyaline deposits,&#x000a0;while&#x000a0;LCD presents with amyloid-like inclusions.<xref ref-type="bibr" rid="article-93295.r2">[2]</xref>&#x000a0;GCD type 2, or Avellino-type, can present with both hyaline and amyloid-like deposits histologically.<xref ref-type="bibr" rid="article-93295.r2">[2]</xref><xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;In FECD,&#x000a0;there is&#x000a0;a thickened Descemet&#x02019;s membrane with guttae expressed as hyaline outgrowths from the membrane.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;Reis-Behnke&#x000a0;CD and GCD&#x000a0;are positive for rod or trapezoidal-like inclusions found in the stroma.<xref ref-type="bibr" rid="article-93295.r2">[2]</xref><xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;Schnyder&#x000a0;CD finds cholesterol deposits in the stroma.<xref ref-type="bibr" rid="article-93295.r2">[2]</xref><xref ref-type="bibr" rid="article-93295.r20">[20]</xref>&#x000a0;</p>
        <p>Staining of histologic slides is crucial to diagnose some forms of CD, as it may lead to the type of substance deposited in the cornea. Many dystrophies that include a mutation in TGFBI, like LCD and GCD, will stain positive for Congo&#x000a0;red, as these dystrophies produce an amyloid-like disease.<xref ref-type="bibr" rid="article-93295.r2">[2]</xref><xref ref-type="bibr" rid="article-93295.r15">[15]</xref>&#x000a0;Other amyloid positive dystrophies, such as GCD,&#x000a0;also stain positive with Masson Trichrome&#x000a0;and show eosinophilic deposits on H&#x00026;E.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;Trichrome staining is also helpful for distinguishing the subepithelial mucoid material found in SMCD.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;Periodic acid-Schiff (PAS), which stains polysaccharides and glycogen, can be positive in&#x000a0;Meesmann&#x000a0;CD, as well as highlight the intraepithelial cysts found in the disease.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r2">[2]</xref>&#x000a0;Alcian-blue, which stains for acid mucins, will&#x000a0;stain&#x000a0;positive in Fleck&#x000a0;CD, MCD, ERED, and Subepithelial&#x000a0;Mucinous&#x000a0;CD.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;In addition, colloidal iron will be positive in MCD, due to the accumulation of&#x000a0;glycosaminoglycans in all layers of the cornea.<xref ref-type="bibr" rid="article-93295.r22">[22]</xref>&#x000a0;Drop-like gelatinous CD stains positive for lactoferrin antibodies,&#x000a0;even though&#x000a0;the deposits are amyloid in nature.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;Posterior Polymorphous CD will stain positive for cytokeratin, which stains proteins involved in the cytoskeleton of a cell.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;</p>
        <p>Transmission electron microscopy (TEM) is&#x000a0;often&#x000a0;involved&#x000a0;in&#x000a0;academic investigations&#x000a0;of CD, but it can&#x000a0;also&#x000a0;be&#x000a0;used to confirm&#x000a0;the&#x000a0;diagnosis in some dystrophies.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;Certain characteristics found on TEM distinguish one variant of CD from another; for example, in&#x000a0;Meesmann&#x000a0;CD, collections of&#x000a0;fibrogranular&#x000a0;material, as well as mutated&#x000a0;cytokeratin, known as &#x0201c;peculiar substance,&#x0201d; can be found in the cytoplasm.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;TBCD presents with curly subepithelial fibrils.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;Findings in MCD include intracytoplasmic vacuoles with fine&#x000a0;fibrillogranular&#x000a0;material.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref></p>
      </sec>
      <sec id="article-93295.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>In patients who are asymptomatic&#x000a0;or mild&#x000a0;cases of CD,&#x000a0;regular follow-up with the clinician is recommended for any typical ophthalmologic changes, as well as the possibility for any disease progression.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;Regular follow-up appointments for the&#x000a0;slow-progressing variants&#x000a0;are more crucial for proper intervention, with typical&#x000a0;conservative&#x000a0;management including corrective lenses.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;</p>
        <p>Treatment for symptomatic dystrophies&#x000a0;can be organized by anatomic location, as symptoms tend to become similar among dystrophies of the same classification. Elaboration on management for each type of dystrophy will be discussed in other StatPearls articles.</p>
        <p><bold>Epithelial dystrophies</bold>: The most common symptoms seen are corneal erosions, especially in the morning, due to the increase of epithelial sloughing from nocturnal corneal drying.<xref ref-type="bibr" rid="article-93295.r5">[5]</xref><xref ref-type="bibr" rid="article-93295.r51">[51]</xref>&#x000a0;Symptomatic management for recurrent corneal erosions starts with artificial tear administration&#x000a0;to lessen friction caused by blinking, therefore preventing epithelial sloughing.<xref ref-type="bibr" rid="article-93295.r5">[5]</xref>&#x000a0;Hypertonic nighttime&#x000a0;lubricants&#x000a0;can help&#x000a0;reduce friction as well&#x000a0;as decrease corneal edema in the intracellular space.<xref ref-type="bibr" rid="article-93295.r5">[5]</xref><xref ref-type="bibr" rid="article-93295.r51">[51]</xref>&#x000a0;NSAIDs can help reduce pain, as well as bandage contact lenses.<xref ref-type="bibr" rid="article-93295.r5">[5]</xref><xref ref-type="bibr" rid="article-93295.r37">[37]</xref>&#x000a0;In patients with&#x000a0;more&#x000a0;severe erosions,&#x000a0;superficial keratectomy, anterior stromal puncture, and&#x000a0;phototherapeutic keratectomy&#x000a0;(PTK)&#x000a0;are treatment options that may help alleviate symptoms.<xref ref-type="bibr" rid="article-93295.r5">[5]</xref><xref ref-type="bibr" rid="article-93295.r52">[52]</xref>&#x000a0;</p>
        <p><bold>Stromal dystrophies</bold>: CD involving the stroma may most likely lead to visual acuity loss.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;As some dystrophies involve both the epithelium and stroma,&#x000a0;they&#x000a0;are often associated with corneal erosions as well.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;In addition to conservative treatment, as mentioned in the epithelial section before, invasive measures may be needed to resolve symptoms. As opposed to PTK, automated lamellar keratoplasty (ALK) uses a microkeratome to cut deeper in the corneal surface, roughly 100 to 300 microns, to remove aberrant cells involved in the stroma.<xref ref-type="bibr" rid="article-93295.r53">[53]</xref>&#x000a0;In patients with dystrophy involvement down to the posterior basement membrane&#x000a0;(Descemet&#x02019;s), deep automated lamellar keratoplasty (DALK) may be performed to remove more corneal tissue.<xref ref-type="bibr" rid="article-93295.r54">[54]</xref>&#x000a0;</p>
        <p><bold>Endothelial Dystrophies</bold>:&#x000a0;With the advent of&#x000a0;Descemet&#x02019;s stripping endothelial keratoplasty (DSEK)&#x000a0;and Descemet&#x02019;s membrane endothelial keratoplasty (DMEK), the need for penetrating keratoplasty has diminished due to faster recovery, better post-surgical visual acuity, and&#x000a0;decreased graft rejection, because there is no&#x000a0;impact on the anterior face of the&#x000a0;ocular surface&#x000a0;with these procedures.<xref ref-type="bibr" rid="article-93295.r7">[7]</xref><xref ref-type="bibr" rid="article-93295.r28">[28]</xref></p>
        <p>Other techniques that are used presently or may be implemented in the future consist of using&#x000a0;gene or enzyme therapy,&#x000a0;mesenchymal stem cells to replace dystrophic cells, and lipid-based therapies.<xref ref-type="bibr" rid="article-93295.r22">[22]</xref><xref ref-type="bibr" rid="article-93295.r55">[55]</xref>&#x000a0;Rho-kinase inhibitors could be used to&#x000a0;help decrease intraocular pressure in dystrophies causing glaucoma symptoms, as well as&#x000a0;increase endothelial cell adhesion and replication in endothelial dystrophies&#x000a0;such as FECD.<xref ref-type="bibr" rid="article-93295.r56">[56]</xref>&#x000a0;As CD is predominantly a genetic disease, genetic counseling is recommended to those planning to have children.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref></p>
      </sec>
      <sec id="article-93295.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>It is often the case that corneal dystrophies must be differentiated among each other, as clinical presentations may often overlap.&#x000a0;While&#x000a0;biomicroscopy&#x000a0;findings may identify different types of CD, these findings may be similar among dystrophies.&#x000a0;Genetic testing may aid in the differentiation among dystrophies of similar presentations.&#x000a0;&#x000a0;</p>
        <p>The presenting&#x000a0;signs and&#x000a0;symptoms of CD may be due to other ocular diseases.&#x000a0;Recurrent corneal erosions may be caused by non-genetic etiologies.<xref ref-type="bibr" rid="article-93295.r5">[5]</xref>&#x000a0;Corneal degeneration may be due to the aging process or trauma.<xref ref-type="bibr" rid="article-93295.r5">[5]</xref>&#x000a0;Furthermore, the elderly can present with endothelial guttae and basement membrane degeneration without having an etiology of corneal dystrophy.<xref ref-type="bibr" rid="article-93295.r57">[57]</xref>&#x000a0;Other etiologies include infectious keratitis, either bacterial or commonly from Herpes, and neurotrophic keratitis, where degeneration of the cornea happens due to&#x000a0;trigeminal&#x000a0;nerve damage and desensitization.<xref ref-type="bibr" rid="article-93295.r51">[51]</xref><xref ref-type="bibr" rid="article-93295.r58">[58]</xref><xref ref-type="bibr" rid="article-93295.r59">[59]</xref>&#x000a0;Band keratopathy, or the deposition of calcium in the cornea, can come from chronic uveitis, systemic diseases of hypercalcemia, and sarcoidosis, among other diseases.<xref ref-type="bibr" rid="article-93295.r58">[58]</xref>&#x000a0;Salzmann nodular degeneration is an idiopathic process where bilateral blue-white nodules of hyaline are deposited underneath Bowman&#x02019;s membrane.<xref ref-type="bibr" rid="article-93295.r58">[58]</xref>&#x000a0;The crocodile shagreen seen in&#x000a0;central cloudy dystrophy is typically an idiopathic finding in the elderly. So dystrophy should be included in the differential if these findings are present in children and adolescents.&#x000a0;&#x000a0;</p>
        <p>A patient with corneal erosions could also be affected with Herpes keratitis, infectious keratitis, conjunctival foreign bodies, dry eyes secondary to autoimmune disease, among other pathophysiological processes.<xref ref-type="bibr" rid="article-93295.r5">[5]</xref>&#x000a0;As mentioned before, ocular pain and visual disturbances found in glaucoma can present similarly in some types of CD2&#x000a0;or even be in conjunction with CD, as is the case with&#x000a0;congenital stromal&#x000a0;CD.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;Sometimes, the differential could include other types of corneal dystrophy, as they tend to present with similar symptoms. For example, thorough genetic testing can help differentiate between&#x000a0;Meesmann&#x000a0;CD and&#x000a0;Lisch&#x000a0;epithelial&#x000a0;CD, as well as&#x000a0;all&#x000a0;the dystrophies that cause recurrent corneal erosions.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;GCD can present with similar lesions found in monoclonal gammopathies.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;SCD can be found with systemic signs of hyperlipidemia, which are similarly found in inheritable diseases such as lecithin: cholesterol acyltransferase (LCAT) disease.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;Diseases that affect basement membranes, such as Alport syndrome and Usher syndrome, could potentially present with ocular symptoms&#x000a0;like&#x000a0;CD.<xref ref-type="bibr" rid="article-93295.r60">[60]</xref><xref ref-type="bibr" rid="article-93295.r61">[61]</xref></p>
      </sec>
      <sec id="article-93295.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of CD depends mainly on the subtype of dystrophy.&#x000a0;However,&#x000a0;most CD presents with progressive loss of visual acuity.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;Posterior&#x000a0;Amorphous&#x000a0;CD&#x000a0;is&#x000a0;virtually asymptomatic, only presenting with mild visual refractive error.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;Some dystrophies, like posterior&#x000a0;polymorphous&#x000a0;CD,&#x000a0;Meesmann&#x000a0;CD,&#x000a0;and Fleck&#x000a0;CD, present early in life but tend to progress slowly, requiring little treatment in some cases.<xref ref-type="bibr" rid="article-93295.r2">[2]</xref><xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;Others, like FECD, will progress more rapidly, enough to warrant surgical intervention by the sixth decade of life.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref>&#x000a0;Also, MCD, GDLD, and congenital&#x000a0;stromal&#x000a0;CD can present severely&#x000a0;early in onset, threatening&#x000a0;severe vision loss&#x000a0;in patients who&#x000a0;do not&#x000a0;receive keratoplasty.<xref ref-type="bibr" rid="article-93295.r2">[2]</xref>&#x000a0;&#x000a0;</p>
        <p>There is a&#x000a0;chance&#x000a0;that recurrence of&#x000a0;the dystrophy&#x000a0;can happen post-graft&#x000a0;transplantation, requiring retreatment.&#x000a0;It is more likely to&#x000a0;occur&#x000a0;in stromal dystrophies.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref>&#x000a0;For example, it is reported that LCD&#x000a0;recurrence&#x000a0;after keratoplasty&#x000a0;at&#x000a0;nine&#x000a0;years is 60%, and&#x000a0;GCD may reoccur on an average of&#x000a0;2-3 years&#x000a0;post-surgery.<xref ref-type="bibr" rid="article-93295.r4">[4]</xref><xref ref-type="bibr" rid="article-93295.r53">[53]</xref><xref ref-type="bibr" rid="article-93295.r54">[54]</xref>&#x000a0;Recurrence&#x000a0;has been reported in other types of dystrophies&#x000a0;as well, albeit rarely.<xref ref-type="bibr" rid="article-93295.r62">[62]</xref><xref ref-type="bibr" rid="article-93295.r63">[63]</xref>&#x000a0;It should be stated that retreatment is not always&#x000a0;due&#x000a0;to the recurrence of the disease. In patients with FECD,&#x000a0;repeat corneal grafting&#x000a0;is most likely due to&#x000a0;donor corneal detachment, failure,&#x000a0;or endothelial cell-loss,&#x000a0;rather than recurrence of&#x000a0;the dystrophy.<xref ref-type="bibr" rid="article-93295.r7">[7]</xref></p>
      </sec>
      <sec id="article-93295.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications from CD can arise from&#x000a0;untreated&#x000a0;disease, and there are always risks of complications involved with surgical intervention. If not treated, patients with severe forms of CD&#x000a0;may develop progressively worse vision, to the point of severe visual impairment.<xref ref-type="bibr" rid="article-93295.r1">[1]</xref><xref ref-type="bibr" rid="article-93295.r22">[22]</xref>&#x000a0;Corneal erosions&#x000a0;are painful and&#x000a0;can lead to&#x000a0;secondary&#x000a0;keratitis due to excessive rubbing by the patient.<xref ref-type="bibr" rid="article-93295.r64">[64]</xref>&#x000a0;As treatment primarily involves removing the affected corneal tissue and&#x000a0;transplanting&#x000a0;donor tissue, the risk of infection, graft rejection, and treatment failure&#x000a0;are&#x000a0;present.&#x000a0;It is reported that graft rejection can happen in up to 35% of&#x000a0;corneal dystrophy patients&#x000a0;within one year.<xref ref-type="bibr" rid="article-93295.r65">[65]</xref></p>
      </sec>
      <sec id="article-93295.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>It is important to let patients understand the limitations of surgical intervention. Many dystrophies can reoccur in a few years, despite corneal transplant.<xref ref-type="bibr" rid="article-93295.r21">[21]</xref>&#x000a0;For CD that progresses slowly, non-invasive treatment with spectacles and contact lenses is recommended.<xref ref-type="bibr" rid="article-93295.r21">[21]</xref>&#x000a0;</p>
        <p>Patients should be educated on post-surgical safety measures to promote optimal outcomes. Bandage contact lenses may aid in preventing loose sutures and displacement of the graft.<xref ref-type="bibr" rid="article-93295.r64">[64]</xref>&#x000a0;</p>
        <p>The application of artificial tears in the morning may help alleviate corneal erosion pain.</p>
      </sec>
      <sec id="article-93295.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Corneal&#x000a0;dystrophies&#x000a0;are&#x000a0;a collection of&#x000a0;inheritable diseases&#x000a0;leading to cellular&#x000a0;dysfunction&#x000a0;of the cornea.&#x000a0;</p>
        <p>Patients with corneal&#x000a0;dystrophy range from being asymptomatic&#x000a0;to displaying symptoms such as&#x000a0;painful corneal erosions, photophobia, and visual acuity loss,&#x000a0;and can be associated with other systemic symptoms based on the genetic abnormality.&#x000a0;</p>
        <p>Physical exam findings, especially&#x000a0;biomicroscopy, histologic exam, and genetic testing, are vital to the accurate diagnosis of&#x000a0;corneal dystrophies.&#x000a0;</p>
        <p>Treatment can vary from&#x000a0;conservative measures&#x000a0;to corneal transplantation and is&#x000a0;dependent&#x000a0;on disease onset and progression.</p>
      </sec>
      <sec id="article-93295.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Management of corneal dystrophy is a combined effort by many medical professionals. Despite the rarity of these diseases, optometrists and ophthalmologists performing routine screening exams on patients should always be aware of the slit-lamp findings that are pathognomonic of CD. A clinician, as well as medical assistants, technicians, and nurses, should be aware of symptoms and signs of CD and be thorough patient history gathering, especially family history, to increase the chance of recognizing potential dystrophy. Proper communication among team members of these clinical findings is crucial to appropriate diagnosis through&#x000a0;a&#x000a0;physical exam and laboratory testing.&#x000a0;Over-testing&#x000a0;should be avoided&#x000a0;to&#x000a0;limit&#x000a0;the&#x000a0;cost to the patient. Finally, proper communication and education should be given to the patient&#x000a0;regarding&#x000a0;diagnosis and treatment, follow-up, and potential surgical intervention. It is noteworthy that the ICD-10 codes for CD are divided into&#x000a0;six&#x000a0;categories: endothelial, epithelial (Juvenile&#x02019;s), granular, macular, unspecified, and other hereditary corneal dystrophies.</p>
      </sec>
      <sec id="article-93295.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=93295&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=93295">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/corneal-dystrophy/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=93295">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/93295/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=93295">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-93295.s16">
        <fig id="article-93295.image.f1" position="float" orientation="portrait">
          <caption>
            <p>A: Epithelial Basement Membrane Corneal Dystrophy (Map Dot Fingerprint Dystrophy) presents with geographic, map-like erosions on the corneal surface on biomicroscopy. They may present as microcysts or pebble-like. B: Meesmann&#x02019;s Corneal Dystrophy with small, bubble-like inclusions on the corneal surface with biomicroscopy (arrows). Contributed by Majid Moshirfar, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="collage__1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-93295.s17">
        <fig id="article-93295.image.f2" position="float" orientation="portrait">
          <caption>
            <p>A: A typical presentation of a feather-shaped opacity often found in Lisch Corneal Dystrophy. B: Gelatinous Drop-Like Dystrophy with classic mulberry-like nodules on the corneal surface. Contributed by Majid Moshirfar</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="collage__2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-93295.s18">
        <fig id="article-93295.image.f3" position="float" orientation="portrait">
          <caption>
            <p>A: Typical branching opacities found in Lattice Corneal Dystrophy. B: A clear presentation of Granular Corneal Dystrophy, with crumb-like opacities separated by clear corneal surface space. Contributed by Majid Moshirfar, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="collage__3" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-93295.s19">
        <fig id="article-93295.image.f4" position="float" orientation="portrait">
          <caption>
            <p>A: Reis-Bucklers Corneal Dystrophy presents with erosions and biomicroscopic findings similar to EBMCD, with geographic, map-like erosions on the corneal surface. Note the background corneal haze, which is often not seen in EBMCD. B: Macular Corneal Dystrophy presents with a diffuse ground glass-like opacity, as seen in this cornea from the side.&#x000a0; Contributed by Majid Moshirfar, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="collage__4" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-93295.s20">
        <fig id="article-93295.image.f5" position="float" orientation="portrait">
          <caption>
            <p>A: Central guttae are noted centrally in this patient with Fuchs Endothelial Corneal Dystrophy. B: Classic band-like structures in the cornea in patients with Posterior Polymorphous Corneal Dystrophy. Contributed by Majid Moshirfar, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="collage__5" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-93295.s21">
        <title>References</title>
        <ref id="article-93295.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weiss</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>M&#x000f8;ller</surname>
                <given-names>HU</given-names>
              </name>
              <name>
                <surname>Aldave</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Seitz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bredrup</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kivel&#x000e4;</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Munier</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Rapuano</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Nischal</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Sutphin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Busin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Labb&#x000e9;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kenyon</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Kinoshita</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lisch</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>IC3D classification of corneal dystrophies--edition 2.</article-title>
            <source>Cornea</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>34</volume>
            <issue>2</issue>
            <fpage>117</fpage>
            <page-range>117-59</page-range>
            <pub-id pub-id-type="pmid">25564336</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>ZN</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cui</surname>
                <given-names>HP</given-names>
              </name>
            </person-group>
            <article-title>Characteristics of corneal dystrophies: a review from clinical, histological and genetic perspectives.</article-title>
            <source>Int J Ophthalmol</source>
            <year>2016</year>
            <volume>9</volume>
            <issue>6</issue>
            <fpage>904</fpage>
            <page-range>904-13</page-range>
            <pub-id pub-id-type="pmid">27366696</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burns</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>Meesman's corneal dystrophy.</article-title>
            <source>Trans Am Ophthalmol Soc</source>
            <year>1968</year>
            <volume>66</volume>
            <fpage>530</fpage>
            <page-range>530-635</page-range>
            <pub-id pub-id-type="pmid">4181022</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klintworth</surname>
                <given-names>GK</given-names>
              </name>
            </person-group>
            <article-title>Corneal dystrophies.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2009</year>
            <month>Feb</month>
            <day>23</day>
            <volume>4</volume>
            <fpage>7</fpage>
            <pub-id pub-id-type="pmid">19236704</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Hasan</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Simmons</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>MW</given-names>
              </name>
            </person-group>
            <article-title>Recurrent corneal erosion: a comprehensive review.</article-title>
            <source>Clin Ophthalmol</source>
            <year>2019</year>
            <volume>13</volume>
            <fpage>325</fpage>
            <page-range>325-335</page-range>
            <pub-id pub-id-type="pmid">30809089</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vedana</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Villarreal</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Jun</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Fuchs endothelial corneal dystrophy: current perspectives.</article-title>
            <source>Clin Ophthalmol</source>
            <year>2016</year>
            <volume>10</volume>
            <fpage>321</fpage>
            <page-range>321-30</page-range>
            <pub-id pub-id-type="pmid">26937169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feizi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Corneal endothelial cell dysfunction: etiologies and management.</article-title>
            <source>Ther Adv Ophthalmol</source>
            <year>2018</year>
            <season>Jan-Dec</season>
            <volume>10</volume>
            <fpage>2515841418815802</fpage>
            <pub-id pub-id-type="pmid">30560230</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blanco-Kelly</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Rodrigues-Jacy da Silva</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sanchez-Navarro</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Riveiro-Alvarez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lopez-Martinez</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Corton</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ayuso</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>New CDH3 mutation in the first Spanish case of hypotrichosis with juvenile macular dystrophy, a case report.</article-title>
            <source>BMC Med Genet</source>
            <year>2017</year>
            <month>Jan</month>
            <day>07</day>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <pub-id pub-id-type="pmid">28061825</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Verma</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bhatnagar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vasudevan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Keratosis follicularis spinulosa decalvans.</article-title>
            <source>Indian J Dermatol Venereol Leprol</source>
            <year>2016</year>
            <season>Mar-Apr</season>
            <volume>82</volume>
            <issue>2</issue>
            <fpage>214</fpage>
            <page-range>214-6</page-range>
            <pub-id pub-id-type="pmid">26765129</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aldave</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Sonmez</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Elucidating the molecular genetic basis of the corneal dystrophies: are we there yet?</article-title>
            <source>Arch Ophthalmol</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>125</volume>
            <issue>2</issue>
            <fpage>177</fpage>
            <page-range>177-86</page-range>
            <pub-id pub-id-type="pmid">17296893</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chao-Shern</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>DeDionisio</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Jang</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Christie</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nesbit</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>McMullen</surname>
                <given-names>CBT</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of TGFBI corneal dystrophy and molecular diagnostic testing.</article-title>
            <source>Eye (Lond)</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>33</volume>
            <issue>6</issue>
            <fpage>874</fpage>
            <page-range>874-881</page-range>
            <pub-id pub-id-type="pmid">30760895</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ween</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Oehler</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Ricciardelli</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Transforming growth Factor-Beta-Induced Protein (TGFBI)/(&#x003b2;ig-H3): a matrix protein with dual functions in ovarian cancer.</article-title>
            <source>Int J Mol Sci</source>
            <year>2012</year>
            <volume>13</volume>
            <issue>8</issue>
            <fpage>10461</fpage>
            <page-range>10461-10477</page-range>
            <pub-id pub-id-type="pmid">22949874</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kawasaki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nishida</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Quantock</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Dota</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kinoshita</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Amyloid and Pro501 Thr-mutated (beta)ig-h3 gene product colocalize in lattice corneal dystrophy type IIIA.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1999</year>
            <month>Apr</month>
            <volume>127</volume>
            <issue>4</issue>
            <fpage>456</fpage>
            <page-range>456-8</page-range>
            <pub-id pub-id-type="pmid">10218700</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kawashima</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yamada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Funayama</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mashima</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>[Six cases of late-onset lattice corneal dystrophy associated with gene mutations induced by the transforming growth factor-beta].</article-title>
            <source>Nippon Ganka Gakkai Zasshi</source>
            <year>2005</year>
            <month>Feb</month>
            <volume>109</volume>
            <issue>2</issue>
            <fpage>93</fpage>
            <page-range>93-100</page-range>
            <pub-id pub-id-type="pmid">15770959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klintworth</surname>
                <given-names>GK</given-names>
              </name>
            </person-group>
            <article-title>The molecular genetics of the corneal dystrophies--current status.</article-title>
            <source>Front Biosci</source>
            <year>2003</year>
            <month>May</month>
            <day>01</day>
            <volume>8</volume>
            <fpage>d687</fpage>
            <page-range>d687-713</page-range>
            <pub-id pub-id-type="pmid">12700042</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carrwik</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Stenevi</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Lattice corneal dystrophy, gelsolin type (Meretoja's syndrome).</article-title>
            <source>Acta Ophthalmol</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>87</volume>
            <issue>8</issue>
            <fpage>813</fpage>
            <page-range>813-9</page-range>
            <pub-id pub-id-type="pmid">19832730</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Casal</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Monteiro</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Abreu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Neves</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Beir&#x000e3;o</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Meretoja's Syndrome: Lattice Corneal Dystrophy, Gelsolin Type.</article-title>
            <source>Case Rep Med</source>
            <year>2017</year>
            <volume>2017</volume>
            <fpage>2843417</fpage>
            <pub-id pub-id-type="pmid">28250773</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Irvine</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Corden</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Swensson</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Swensson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Frazer</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Knowlton</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Christophers</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rochels</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Uitto</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McLean</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>Mutations in cornea-specific keratin K3 or K12 genes cause Meesmann's corneal dystrophy.</article-title>
            <source>Nat Genet</source>
            <year>1997</year>
            <month>Jun</month>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>184</fpage>
            <page-range>184-7</page-range>
            <pub-id pub-id-type="pmid">9171831</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hassan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Thaung</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ebenezer</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Larkin</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hardcastle</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Tuft</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Severe Meesmann's epithelial corneal dystrophy phenotype due to a missense mutation in the helix-initiation motif of keratin 12.</article-title>
            <source>Eye (Lond)</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>27</volume>
            <issue>3</issue>
            <fpage>367</fpage>
            <page-range>367-73</page-range>
            <pub-id pub-id-type="pmid">23222558</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Evans</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Dudakova</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Skalicka</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mahelkova</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Horinek</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hardcastle</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Tuft</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Liskova</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Schnyder corneal dystrophy and associated phenotypes caused by novel and recurrent mutations in the UBIAD1 gene.</article-title>
            <source>BMC Ophthalmol</source>
            <year>2018</year>
            <month>Sep</month>
            <day>17</day>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>250</fpage>
            <pub-id pub-id-type="pmid">30223810</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kawasaki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kinoshita</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Clinical and basic aspects of gelatinous drop-like corneal dystrophy.</article-title>
            <source>Dev Ophthalmol</source>
            <year>2011</year>
            <volume>48</volume>
            <fpage>97</fpage>
            <page-range>97-115</page-range>
            <pub-id pub-id-type="pmid">21540633</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aggarwal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Peck</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Golen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Karcioglu</surname>
                <given-names>ZA</given-names>
              </name>
            </person-group>
            <article-title>Macular corneal dystrophy: A review.</article-title>
            <source>Surv Ophthalmol</source>
            <year>2018</year>
            <season>Sep-Oct</season>
            <volume>63</volume>
            <issue>5</issue>
            <fpage>609</fpage>
            <page-range>609-617</page-range>
            <pub-id pub-id-type="pmid">29604391</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vithana</surname>
                <given-names>EN</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sundaresan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ebenezer</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Mohamed</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Anand</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khine</surname>
                <given-names>KO</given-names>
              </name>
              <name>
                <surname>Venkataraman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Yong</surname>
                <given-names>VH</given-names>
              </name>
              <name>
                <surname>Salto-Tellez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Venkatraman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hemadevi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Srinivasan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Prajna</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Khine</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Casey</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Inglehearn</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Aung</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Mutations in sodium-borate cotransporter SLC4A11 cause recessive congenital hereditary endothelial dystrophy (CHED2).</article-title>
            <source>Nat Genet</source>
            <year>2006</year>
            <month>Jul</month>
            <volume>38</volume>
            <issue>7</issue>
            <fpage>755</fpage>
            <page-range>755-7</page-range>
            <pub-id pub-id-type="pmid">16767101</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nanda</surname>
                <given-names>GG</given-names>
              </name>
              <name>
                <surname>Alone</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <article-title>REVIEW: Current understanding of the pathogenesis of Fuchs' endothelial corneal dystrophy.</article-title>
            <source>Mol Vis</source>
            <year>2019</year>
            <volume>25</volume>
            <fpage>295</fpage>
            <page-range>295-310</page-range>
            <pub-id pub-id-type="pmid">31263352</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krafchak</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Pawar</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Moroi</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Sugar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lichter</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Mackey</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Mian</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nairus</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Elner</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Schteingart</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Downs</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Kijek</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Trager</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Rozsa</surname>
                <given-names>FW</given-names>
              </name>
              <name>
                <surname>Mandal</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Epstein</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Vollrath</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ayyagari</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Boehnke</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Richards</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Mutations in TCF8 cause posterior polymorphous corneal dystrophy and ectopic expression of COL4A3 by corneal endothelial cells.</article-title>
            <source>Am J Hum Genet</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>77</volume>
            <issue>5</issue>
            <fpage>694</fpage>
            <page-range>694-708</page-range>
            <pub-id pub-id-type="pmid">16252232</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Williams</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Montoya</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Eddy</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Byers</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Shows</surname>
                <given-names>TB</given-names>
              </name>
            </person-group>
            <article-title>The TCF8 gene encoding a zinc finger protein (Nil-2-a) resides on human chromosome 10p11.2.</article-title>
            <source>Genomics</source>
            <year>1992</year>
            <month>Sep</month>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>194</fpage>
            <page-range>194-6</page-range>
            <pub-id pub-id-type="pmid">1427828</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tiab</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jiao</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Munier</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Zografos</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Frueh</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Sergeev</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rubin</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Meallet</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Forster</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Hejtmancik</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Schorderet</surname>
                <given-names>DF</given-names>
              </name>
            </person-group>
            <article-title>Mutations in PIP5K3 are associated with Fran&#x000e7;ois-Neetens mouchet&#x000e9;e fleck corneal dystrophy.</article-title>
            <source>Am J Hum Genet</source>
            <year>2005</year>
            <month>Jul</month>
            <volume>77</volume>
            <issue>1</issue>
            <fpage>54</fpage>
            <page-range>54-63</page-range>
            <pub-id pub-id-type="pmid">15902656</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Okumura</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hayashi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Koizumi</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Perspective of Future Potent Therapies for Fuchs Endothelial Corneal Dystrophy.</article-title>
            <source>Open Ophthalmol J</source>
            <year>2018</year>
            <volume>12</volume>
            <fpage>154</fpage>
            <page-range>154-163</page-range>
            <pub-id pub-id-type="pmid">30123380</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Musch</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Niziol</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Kamyar</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Sugar</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of corneal dystrophies in the United States: estimates from claims data.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2011</year>
            <month>Sep</month>
            <day>01</day>
            <volume>52</volume>
            <issue>9</issue>
            <fpage>6959</fpage>
            <page-range>6959-63</page-range>
            <pub-id pub-id-type="pmid">21791583</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Igo</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Fondran</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mootha</surname>
                <given-names>VV</given-names>
              </name>
              <name>
                <surname>Oliva</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hammersmith</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sugar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lass</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Iyengar</surname>
                <given-names>SK</given-names>
              </name>
              <collab>Fuchs' Genetics Multi-Center Study Group</collab>
            </person-group>
            <article-title>Association of smoking and other risk factors with Fuchs' endothelial corneal dystrophy severity and corneal thickness.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2013</year>
            <month>Aug</month>
            <day>27</day>
            <volume>54</volume>
            <issue>8</issue>
            <fpage>5829</fpage>
            <page-range>5829-35</page-range>
            <pub-id pub-id-type="pmid">23882692</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaza</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Barik</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Reddy</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Mittal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Gelatinous drop-like corneal dystrophy: a review.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>101</volume>
            <issue>1</issue>
            <fpage>10</fpage>
            <page-range>10-15</page-range>
            <pub-id pub-id-type="pmid">27913443</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ehlers</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hjortdal</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nielsen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Thiel</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>&#x000d8;rntoft</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Phenotypic variability in Meesmann's dystrophy: clinical review of the literature and presentation of a family genetically identical to the original family.</article-title>
            <source>Acta Ophthalmol</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>86</volume>
            <issue>1</issue>
            <fpage>40</fpage>
            <page-range>40-4</page-range>
            <pub-id pub-id-type="pmid">17986293</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sridhar</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Anatomy of cornea and ocular surface.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>66</volume>
            <issue>2</issue>
            <fpage>190</fpage>
            <page-range>190-194</page-range>
            <pub-id pub-id-type="pmid">29380756</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ali</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Raghunathan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Thomasy</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Biomechanical relationships between the corneal endothelium and Descemet's membrane.</article-title>
            <source>Exp Eye Res</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>152</volume>
            <fpage>57</fpage>
            <page-range>57-70</page-range>
            <pub-id pub-id-type="pmid">27639516</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Geroski</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Matsuda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yee</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Edelhauser</surname>
                <given-names>HF</given-names>
              </name>
            </person-group>
            <article-title>Pump function of the human corneal endothelium. Effects of age and cornea guttata.</article-title>
            <source>Ophthalmology</source>
            <year>1985</year>
            <month>Jun</month>
            <volume>92</volume>
            <issue>6</issue>
            <fpage>759</fpage>
            <page-range>759-63</page-range>
            <pub-id pub-id-type="pmid">2412197</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oregel</surname>
                <given-names>KZ</given-names>
              </name>
              <name>
                <surname>Shouse</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Oster</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Martinez</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rosenzweig</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Deisch</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Nagaraj</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Atypical Presentation of Gelsolin Amyloidosis in a Man of African Descent with a Novel Mutation in the Gelsolin Gene.</article-title>
            <source>Am J Case Rep</source>
            <year>2018</year>
            <month>Mar</month>
            <day>30</day>
            <volume>19</volume>
            <fpage>374</fpage>
            <page-range>374-381</page-range>
            <pub-id pub-id-type="pmid">29599423</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bourges</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Corneal dystrophies.</article-title>
            <source>J Fr Ophtalmol</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>40</volume>
            <issue>6</issue>
            <fpage>e177</fpage>
            <page-range>e177-e192</page-range>
            <pub-id pub-id-type="pmid">28583694</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r38">
          <label>38</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>R&#x000f8;dahl</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Knappskog</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Bredrup</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Boman</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <chapter-title>Congenital Stromal Corneal Dystrophy</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>2008</year>
            <month>11</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">20301741</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lisch</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bron</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Munier</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Schorderet</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Tiab</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lange</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Saikia</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Reinhard</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Gundlach</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pleyer</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Lisch</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Auw-Haedrich</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Franceschetti hereditary recurrent corneal erosion.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>153</volume>
            <issue>6</issue>
            <fpage>1073</fpage>
            <page-range>1073-81.e4</page-range>
            <pub-id pub-id-type="pmid">22402249</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feder</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Jay</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yue</surname>
                <given-names>BY</given-names>
              </name>
              <name>
                <surname>Stock</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>O'Grady</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Roth</surname>
                <given-names>SI</given-names>
              </name>
            </person-group>
            <article-title>Subepithelial mucinous corneal dystrophy. Clinical and pathological correlations.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1993</year>
            <month>Aug</month>
            <volume>111</volume>
            <issue>8</issue>
            <fpage>1106</fpage>
            <page-range>1106-14</page-range>
            <pub-id pub-id-type="pmid">8352693</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pole</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sise</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Joag</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Galor</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bermudez-Magner</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Dubovy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Karp</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>High-Resolution Optical Coherence Tomography Findings of Lisch Epithelial Corneal Dystrophy.</article-title>
            <source>Cornea</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>35</volume>
            <issue>3</issue>
            <fpage>392</fpage>
            <page-range>392-4</page-range>
            <pub-id pub-id-type="pmid">26764880</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kiuru-Enari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Keski-Oja</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Haltia</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Cutis laxa in hereditary gelsolin amyloidosis.</article-title>
            <source>Br J Dermatol</source>
            <year>2005</year>
            <month>Feb</month>
            <volume>152</volume>
            <issue>2</issue>
            <fpage>250</fpage>
            <page-range>250-7</page-range>
            <pub-id pub-id-type="pmid">15727635</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Le</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Frausto</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Croasdale</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Yee</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Hejtmancik</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Aldave</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Whole Exome Sequencing and Segregation Analysis Confirms That a Mutation in COL17A1 Is the Cause of Epithelial Recurrent Erosion Dystrophy in a Large Dominant Pedigree Previously Mapped to Chromosome 10q23-q24.</article-title>
            <source>PLoS One</source>
            <year>2016</year>
            <volume>11</volume>
            <issue>6</issue>
            <fpage>e0157418</fpage>
            <pub-id pub-id-type="pmid">27309958</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>K&#x000fc;chle</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>V&#x000f6;lcker</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Barraquer</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Reevaluation of corneal dystrophies of Bowman's layer and the anterior stroma (Reis-B&#x000fc;cklers and Thiel-Behnke types): a light and electron microscopic study of eight corneas and a review of the literature.</article-title>
            <source>Cornea</source>
            <year>1995</year>
            <month>Jul</month>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>333</fpage>
            <page-range>333-54</page-range>
            <pub-id pub-id-type="pmid">7671605</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bramsen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ehlers</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Baggesen</surname>
                <given-names>LH</given-names>
              </name>
            </person-group>
            <article-title>Central cloudy corneal dystrophy of Fran&#x000e7;ois.</article-title>
            <source>Acta Ophthalmol (Copenh)</source>
            <year>1976</year>
            <month>Apr</month>
            <volume>54</volume>
            <issue>2 p</issue>
            <fpage>221</fpage>
            <page-range>221-6</page-range>
            <pub-id pub-id-type="pmid">1083619</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moshegov</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Hoe</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Wiffen</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Daya</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Posterior amorphous corneal dystrophy. A new pedigree with phenotypic variation.</article-title>
            <source>Ophthalmology</source>
            <year>1996</year>
            <month>Mar</month>
            <volume>103</volume>
            <issue>3</issue>
            <fpage>474</fpage>
            <page-range>474-8</page-range>
            <pub-id pub-id-type="pmid">8600425</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Pre-Descemet's corneal dystrophy associated with ichthyosis.</article-title>
            <source>Zhonghua Yi Xue Za Zhi (Taipei)</source>
            <year>2002</year>
            <month>Aug</month>
            <volume>65</volume>
            <issue>8</issue>
            <fpage>407</fpage>
            <page-range>407-9</page-range>
            <pub-id pub-id-type="pmid">12455812</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fujimoto</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Maeda</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Soma</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Oie</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Koh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tsujikawa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nishida</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Quantitative regional differences in corneal endothelial abnormalities in the central and peripheral zones in Fuchs' endothelial corneal dystrophy.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2014</year>
            <month>Jul</month>
            <day>24</day>
            <volume>55</volume>
            <issue>8</issue>
            <fpage>5090</fpage>
            <page-range>5090-8</page-range>
            <pub-id pub-id-type="pmid">25061116</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chaurasia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mittal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bichappa</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ramappa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Murthy</surname>
                <given-names>SI</given-names>
              </name>
            </person-group>
            <article-title>Clinical characterization of posterior polymorphous corneal dystrophy in patients of Indian ethnicity.</article-title>
            <source>Int Ophthalmol</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>37</volume>
            <issue>4</issue>
            <fpage>945</fpage>
            <page-range>945-952</page-range>
            <pub-id pub-id-type="pmid">27658681</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schmid</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lisch</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Philipp</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Lechner</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>G&#x000f6;ttinger</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Schl&#x000f6;tzer-Schrehardt</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Utermann</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Janecke</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>A new, X-linked endothelial corneal dystrophy.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>141</volume>
            <issue>3</issue>
            <fpage>478</fpage>
            <page-range>478-487</page-range>
            <pub-id pub-id-type="pmid">16490493</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramamurthi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>MQ</given-names>
              </name>
              <name>
                <surname>Dutton</surname>
                <given-names>GN</given-names>
              </name>
              <name>
                <surname>Ramaesh</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis, clinical features and management of recurrent corneal erosions.</article-title>
            <source>Eye (Lond)</source>
            <year>2006</year>
            <month>Jun</month>
            <volume>20</volume>
            <issue>6</issue>
            <fpage>635</fpage>
            <page-range>635-44</page-range>
            <pub-id pub-id-type="pmid">16021185</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reidy</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Paulus</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Gona</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Recurrent erosions of the cornea: epidemiology and treatment.</article-title>
            <source>Cornea</source>
            <year>2000</year>
            <month>Nov</month>
            <volume>19</volume>
            <issue>6</issue>
            <fpage>767</fpage>
            <page-range>767-71</page-range>
            <pub-id pub-id-type="pmid">11095047</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arora</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Deep anterior lamellar keratoplasty or penetrating keratoplasty in lattice corneal dystrophy.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2018</year>
            <month>May</month>
            <volume>66</volume>
            <issue>5</issue>
            <fpage>673</fpage>
            <page-range>673-674</page-range>
            <pub-id pub-id-type="pmid">29676313</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lewis</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Price</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Feng</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Price</surname>
                <given-names>FW</given-names>
              </name>
            </person-group>
            <article-title>Recurrence of Granular Corneal Dystrophy Type 1 After Phototherapeutic Keratectomy, Lamellar Keratoplasty, and Penetrating Keratoplasty in a Single Population.</article-title>
            <source>Cornea</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>36</volume>
            <issue>10</issue>
            <fpage>1227</fpage>
            <page-range>1227-1232</page-range>
            <pub-id pub-id-type="pmid">28749898</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rowsey</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Karamichos</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>The role of lipids in corneal diseases and dystrophies: a systematic review.</article-title>
            <source>Clin Transl Med</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>30</fpage>
            <pub-id pub-id-type="pmid">28782089</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moshirfar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Parker</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Birdsong</surname>
                <given-names>OC</given-names>
              </name>
              <name>
                <surname>Ronquillo</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Hofstedt</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Gomez</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Hoopes</surname>
                <given-names>PCS</given-names>
              </name>
            </person-group>
            <article-title>Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature.</article-title>
            <source>Med Hypothesis Discov Innov Ophthalmol</source>
            <year>2018</year>
            <season>Fall</season>
            <volume>7</volume>
            <issue>3</issue>
            <fpage>101</fpage>
            <page-range>101-111</page-range>
            <pub-id pub-id-type="pmid">30386798</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lorenzetti</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Uotila</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Parikh</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kaufman</surname>
                <given-names>HE</given-names>
              </name>
            </person-group>
            <article-title>Central cornea guttata. Incidence in the general population.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1967</year>
            <month>Dec</month>
            <volume>64</volume>
            <issue>6</issue>
            <fpage>1155</fpage>
            <page-range>1155-8</page-range>
            <pub-id pub-id-type="pmid">6072991</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mansour</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Haddad</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Optical coherence tomography of band keratopathy.</article-title>
            <source>BMJ Case Rep</source>
            <year>2016</year>
            <month>Dec</month>
            <day>30</day>
            <volume>2016</volume>
            <pub-id pub-id-type="pmid">28039348</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roszkowska</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Aragona</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Spinella</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pisani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Puzzolo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Micali</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Morphologic and confocal investigation on Salzmann nodular degeneration of the cornea.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2011</year>
            <month>Jul</month>
            <day>29</day>
            <volume>52</volume>
            <issue>8</issue>
            <fpage>5910</fpage>
            <page-range>5910-9</page-range>
            <pub-id pub-id-type="pmid">21705683</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gr&#x000fc;nfeld</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>The clinical spectrum of hereditary nephritis.</article-title>
            <source>Kidney Int</source>
            <year>1985</year>
            <month>Jan</month>
            <volume>27</volume>
            <issue>1</issue>
            <fpage>83</fpage>
            <page-range>83-92</page-range>
            <pub-id pub-id-type="pmid">3981875</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Calvet</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lahlou</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Safieddine</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>[Gene therapy progress: hopes for Usher syndrome].</article-title>
            <source>Med Sci (Paris)</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>34</volume>
            <issue>10</issue>
            <fpage>842</fpage>
            <page-range>842-848</page-range>
            <pub-id pub-id-type="pmid">30451679</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marcon</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Rapuano</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Laibson</surname>
                <given-names>PR</given-names>
              </name>
            </person-group>
            <article-title>Recurrence of corneal stromal dystrophies after penetrating keratoplasty.</article-title>
            <source>Cornea</source>
            <year>2003</year>
            <month>Jan</month>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>19</fpage>
            <page-range>19-21</page-range>
            <pub-id pub-id-type="pmid">12502942</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boruchoff</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Weiner</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Albert</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Recurrence of posterior polymorphous corneal dystrophy after penetrating keratoplasty.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1990</year>
            <month>Mar</month>
            <day>15</day>
            <volume>109</volume>
            <issue>3</issue>
            <fpage>323</fpage>
            <page-range>323-8</page-range>
            <pub-id pub-id-type="pmid">2309866</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fan Gaskin</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Good</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Jordan</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>DV</given-names>
              </name>
              <name>
                <surname>McGhee</surname>
                <given-names>CNj</given-names>
              </name>
            </person-group>
            <article-title>The Auckland keratoconus study: identifying predictors of acute corneal hydrops in keratoconus.</article-title>
            <source>Clin Exp Optom</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>96</volume>
            <issue>2</issue>
            <fpage>208</fpage>
            <page-range>208-13</page-range>
            <pub-id pub-id-type="pmid">23432147</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93295.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharif</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Casey</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Penetrating keratoplasty for keratoconus: complications and long-term success.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1991</year>
            <month>Mar</month>
            <volume>75</volume>
            <issue>3</issue>
            <fpage>142</fpage>
            <page-range>142-6</page-range>
            <pub-id pub-id-type="pmid">1826453</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
